158 related articles for article (PubMed ID: 20554520)
1. Altered VEGF mRNA stability following treatments with immunosuppressive agents: implications for cancer development.
Basu A; Datta D; Zurakowski D; Pal S
J Biol Chem; 2010 Aug; 285(33):25196-202. PubMed ID: 20554520
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin inhibitor-induced and Ras-mediated overexpression of VEGF in renal cancer cells involves mTOR through the regulation of PRAS40.
Basu A; Banerjee P; Contreras AG; Flynn E; Pal S
PLoS One; 2011; 6(8):e23919. PubMed ID: 21886838
[TBL] [Abstract][Full Text] [Related]
3. Antagonistic functions of tetradecanoyl phorbol acetate-inducible-sequence 11b and HuR in the hormonal regulation of vascular endothelial growth factor messenger ribonucleic acid stability by adrenocorticotropin.
Cherradi N; Lejczak C; Desroches-Castan A; Feige JJ
Mol Endocrinol; 2006 Apr; 20(4):916-30. PubMed ID: 16306087
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human astrocytic tumors.
Ido K; Nakagawa T; Sakuma T; Takeuchi H; Sato K; Kubota T
Neuropathology; 2008 Dec; 28(6):604-11. PubMed ID: 18498284
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C activation affects, via the mRNA-binding Hu-antigen R/ELAV protein, vascular endothelial growth factor expression in a pericytic/endothelial coculture model.
Amadio M; Osera C; Lupo G; Motta C; Drago F; Govoni S; Pascale A
Mol Vis; 2012; 18():2153-64. PubMed ID: 22879735
[TBL] [Abstract][Full Text] [Related]
6. Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human meningiomas.
Sakuma T; Nakagawa T; Ido K; Takeuchi H; Sato K; Kubota T
J Neurooncol; 2008 Jun; 88(2):143-55. PubMed ID: 18317686
[TBL] [Abstract][Full Text] [Related]
7. Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA.
Doller A; Akool el-S; Huwiler A; Müller R; Radeke HH; Pfeilschifter J; Eberhardt W
Mol Cell Biol; 2008 Apr; 28(8):2608-25. PubMed ID: 18285462
[TBL] [Abstract][Full Text] [Related]
8. HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium.
Kurosu T; Ohga N; Hida Y; Maishi N; Akiyama K; Kakuguchi W; Kuroshima T; Kondo M; Akino T; Totsuka Y; Shindoh M; Higashino F; Hida K
Br J Cancer; 2011 Mar; 104(5):819-29. PubMed ID: 21285980
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer.
Basu A; Contreras AG; Datta D; Flynn E; Zeng L; Cohen HT; Briscoe DM; Pal S
Cancer Res; 2008 Jul; 68(14):5689-98. PubMed ID: 18632621
[TBL] [Abstract][Full Text] [Related]
10. Il-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability.
Cuneo AA; Herrick D; Autieri MV
J Mol Cell Cardiol; 2010 Oct; 49(4):647-54. PubMed ID: 20451530
[TBL] [Abstract][Full Text] [Related]
11. Polyamines regulate the stability of activating transcription factor-2 mRNA through RNA-binding protein HuR in intestinal epithelial cells.
Xiao L; Rao JN; Zou T; Liu L; Marasa BS; Chen J; Turner DJ; Zhou H; Gorospe M; Wang JY
Mol Biol Cell; 2007 Nov; 18(11):4579-90. PubMed ID: 17804813
[TBL] [Abstract][Full Text] [Related]
12. Tandem phosphorylation of serines 221 and 318 by protein kinase Cdelta coordinates mRNA binding and nucleocytoplasmic shuttling of HuR.
Doller A; Schlepckow K; Schwalbe H; Pfeilschifter J; Eberhardt W
Mol Cell Biol; 2010 Mar; 30(6):1397-410. PubMed ID: 20086103
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR.
Levy NS; Chung S; Furneaux H; Levy AP
J Biol Chem; 1998 Mar; 273(11):6417-23. PubMed ID: 9497373
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C alpha-dependent phosphorylation of the mRNA-stabilizing factor HuR: implications for posttranscriptional regulation of cyclooxygenase-2.
Doller A; Huwiler A; Müller R; Radeke HH; Pfeilschifter J; Eberhardt W
Mol Biol Cell; 2007 Jun; 18(6):2137-48. PubMed ID: 17392515
[TBL] [Abstract][Full Text] [Related]
15. von Hippel-Lindau tumor suppressor gene-dependent mRNA stabilization of the survival factor parathyroid hormone-related protein in human renal cell carcinoma by the RNA-binding protein HuR.
Danilin S; Sourbier C; Thomas L; Rothhut S; Lindner V; Helwig JJ; Jacqmin D; Lang H; Massfelder T
Carcinogenesis; 2009 Mar; 30(3):387-96. PubMed ID: 19056930
[TBL] [Abstract][Full Text] [Related]
16. Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR): implications for impaired post-transcriptional regulation of vascular endothelial growth factor.
Lu L; Wang S; Zheng L; Li X; Suswam EA; Zhang X; Wheeler CG; Nabors LB; Filippova N; King PH
J Biol Chem; 2009 Dec; 284(49):33989-98. PubMed ID: 19805546
[TBL] [Abstract][Full Text] [Related]
17. The PPARβ agonist L-165041 promotes VEGF mRNA stabilization in HPV18-harboring HeLa cells through a receptor-independent mechanism.
Roche E; Lascombe I; Bittard H; Mougin C; Fauconnet S
Cell Signal; 2014 Feb; 26(2):433-43. PubMed ID: 24172859
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide destabilizes cyclooxygenase-2 mRNA by inhibiting p38 mitogen-activated protein kinase and cytoplasmic shuttling of HuR.
Jin SH; Kim TI; Yang KM; Kim WH
Eur J Pharmacol; 2007 Mar; 558(1-3):14-20. PubMed ID: 17208222
[TBL] [Abstract][Full Text] [Related]
19. Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine/uridine-rich stability elements in the vascular endothelial growth factor 3'-untranslated region.
Li X; Lu L; Bush DJ; Zhang X; Zheng L; Suswam EA; King PH
J Neurochem; 2009 Feb; 108(4):1032-44. PubMed ID: 19196430
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progression.
Basu A; Liu T; Banerjee P; Flynn E; Zurakowski D; Datta D; Viklicky O; Gasser M; Waaga-Gasser AM; Yang J; Pal S
Cancer Lett; 2012 Aug; 321(2):179-86. PubMed ID: 22343319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
